Drug Approval | June 23, 2025
Unichem receives Form 483 from USFDA with 3 observations for Roha API facility
The company will provide the necessary response to USFDA within stipulated 15 days
The company will provide the necessary response to USFDA within stipulated 15 days
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
The proceeds from the QIP will be utiized for purchase of outstanding optionally convertible debentures
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
The company received one observation in the Form-483
Prasinezumab is a potential first-in-class anti-alpha-synuclein antibody, targeting a known biological driver of Parkinson’s disease progression
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The company received 1 (One) observation in the Form-483
Dilip Shanghvi to continue as the Executive Chairman of the Board
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Subscribe To Our Newsletter & Stay Updated
